Layered GelMA/PEGDA Hydrogel Microneedle Patch as an Intradermal Delivery System for Hypertrophic Scar Treatment
- 9 September 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 15 (37) , 43309-43320
Abstract
Hypertrophic scar (HS) is an unfavorable skin disorder that typically develops after trauma, burn injury, or surgical procedures and causes numerous physical and psychological issues in patients. Currently, intralesional multi-injection of corticosteroid, particularly compound betamethasone (CB), is one of the most prevalent treatments for HS. However, injection administration could result in severe pain and dose-related side effects. Additionally, the vacuum therapeutic efficacy of this treatment relies on the level of expertise of the healthcare professional. To overcome the limitations of conventional injections, a new method that is convenient, painless, and self-administrable is urgently required. In this study, we developed a methacrylate gelatin (GelMA)/polyethylene glycol diacrylate (PEGDA) double-network hydrogel microneedle patch loaded with CB (CB-HMNP) as an intradermal delivery system for HS treatment. The double-network structure conferred the CB-HMNP with sufficient mechanical properties to successfully penetrate scar tissue while also helping to regulate the drug's sustained release rate. Subsequently, we confirmed that the CB-HMNP had a pronounced inhibitory effect on human HS fibroblasts (hHSFs), whereas drug-free HMNPs had no effect on hHSFs, indicating its high biocompatibility. In order to assess the therapeutic efficacy of CB-HMNPs, HS models of New Zealand rabbit ears were developed. The administration of CB-HMNP three times significantly decreased the scar elevation index (SEI), collagen I/III, and transforming growth factor-β1 (TGF-β1) protein. Therefore, the CB-HMNP may offer an administration pathway for the treatment of HS that is less painful, more convenient, less invasive, and sustain-released.Keywords
Funding Information
- Basic and Applied Basic Research Foundation of Guangdong Province (2022A1515010592, 2023A1515010107)
- Guangzhou Municipal Science and Technology Project (201707010267)
- National Natural Science Foundation of China (31971284)
This publication has 38 references indexed in Scilit:
- Topical clobetasol in conjunction with topical tretinoin is effective in preventing scar formation after superficial partial-thickness burn ulcers of the skin: A retrospective studyJournal of Dermatological Treatment, 2014
- The effect of topical scar treatment on postoperative scar pain and pruritus after total knee arthroplastyArchives of orthopaedic and trauma surgery, 2014
- Treatment of Keloids and Hypertrophic Scars with Bleomycin and ElectroporationPlastic and Reconstructive Surgery, 2013
- Stiff gelatin hydrogels can be photo-chemically synthesized from low viscous gelatin solutions using molecularly functionalized gelatin with a high degree of methacrylationJournal of Materials Science: Materials in Medicine, 2012
- Hydrogel‐Forming Microneedle Arrays for Enhanced Transdermal Drug DeliveryAdvanced Functional Materials, 2012
- The effect of surgical denervation on prevention of excessive dermal scarring: A study on rabbit ear hypertrophic scar modelJournal of Plastic, Reconstructive & Aesthetic Surgery, 2011
- Fibroblasts from the growing margin of keloid scars produce higher levels of collagen I and III compared with intralesional and extralesional sites: clinical implications for lesional site-directed therapyBritish Journal of Dermatology, 2010
- Is Radiation Therapy for Keloids Acceptable? The Risk of Radiation-Induced CarcinogenesisPlastic and Reconstructive Surgery, 2009
- Nonsurgical Management of Hypertrophic Scars: Evidence-Based Therapies, Standard Practices, and Emerging MethodsAesthetic Plastic Surgery, 2007
- Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture forceJournal of Biomechanics, 2004